Literature DB >> 6496140

[1,1-dioxo-1,4,2-benzodithiazine derivatives. I. Synthesis of various 7-carboxy-3-mercapto-1,1-dioxo-1,4,2-benzodithiazine].

Z Brzozowski, J Sławiński.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6496140

Source DB:  PubMed          Journal:  Acta Pol Pharm        ISSN: 0001-6837            Impact factor:   0.330


× No keyword cloud information.
  5 in total

1.  Synthesis and in vitro activity of novel 2-(benzylthio)-4-chloro-5-(1,3,4-oxadiazol-2-yl)benzenesulfonamide derivatives.

Authors:  Kamil Brożewicz; Jarosław Sławiński
Journal:  Monatsh Chem       Date:  2012-03-02       Impact factor: 1.451

2.  New 2-[(4-Amino-6-N-substituted-1,3,5-triazin-2-yl)methylthio]-N-(imidazolidin-2-ylidene)-4-chloro-5-methylbenzenesulfonamide Derivatives, Design, Synthesis and Anticancer Evaluation.

Authors:  Łukasz Tomorowicz; Beata Żołnowska; Krzysztof Szafrański; Jarosław Chojnacki; Ryszard Konopiński; Ewa A Grzybowska; Jarosław Sławiński; Anna Kawiak
Journal:  Int J Mol Sci       Date:  2022-06-28       Impact factor: 6.208

3.  Synthesis of a new series of biologically interesting 6'-chloro-1',1'-dioxospiro[4H-benzo[d][1,3,7]oxadiazocine-4,3'(2'H)-[1,4,2]benzodithiazine]-2,6(1H,5H)dione derivatives.

Authors:  Zdzisław Brzozowski; Beata Żołnowska; Jarosław Sławiński
Journal:  Monatsh Chem       Date:  2013-06-11       Impact factor: 1.451

4.  Synthesis and QSAR study of novel 6-chloro-3-(2-Arylmethylene-1-methylhydrazino)-1,4,2-benzodithiazine 1,1-dioxide derivatives with anticancer activity.

Authors:  Jarosław Sławiński; Beata Żołnowska; Zdzisław Brzozowski; Anna Kawiak; Mariusz Belka; Tomasz Bączek
Journal:  Molecules       Date:  2015-04-01       Impact factor: 4.411

5.  Synthesis, cytotoxicity testing, and structure-activity relationships of novel 6-chloro-7-(4-phenylimino-4H-3,1-benzoxazin-2-yl)-3-(substituted)-1,4,2-benzodithiazine 1,1-dioxides.

Authors:  Elżbieta Pomarnacka; Anita Kornicka; Anna Kuchnio; Maike Heinrichs; Renate Grünert; Maria Gdaniec; Patrick J Bednarski
Journal:  Arch Pharm (Weinheim)       Date:  2011-05-25       Impact factor: 3.751

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.